Company intelligence
Dia Beta Labs Ltd
Target-led management of the causes of metabolic disease
Biotechnology Research
Coleraine, GB
6 employees
Founded 2022
1 public signals
About Dia Beta Labs Ltd
Diabetes currently effects over 537 million adults worldwide, with obesity-driven Type 2 Diabetes accounting for over 90% of cases. Dia Beta Labs build on over 30 years of high-impact research from our founding research group at Ulster University to realise the potential of next-generation therapeutics for metabolic disease. It is our goal to impart significant and much-needed change in the management of the global diabetes/obesity crisis.
Verified activity
Signals from Dia Beta Labs Ltd
1 published signal